Anand Rathi has given Buy recommendation for Zydus Wellness with a target price of Rs. 2140 in its research report issued on Sep 23, 2022

Anand Rathi’s research report on Zydus Wellness

Uniquely placed in FMCG with all its major brands in Health & Wellness (unlike many of its FMCG peers), Zydus Wellness’ leadership in five of its six major brands, Rs50bn revenue target in five years and aiming to return to 20%+ EBITDA margins offer comfort on its growth focus.


We initiate coverage on the stock with a Buy recommendation, at a TP of Rs.2,140 (30x Sep’24e EPS of Rs71.3) suggesting 33% potential from the CMP.

Leave a Reply

Your email address will not be published. Required fields are marked *